DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price Down 3.6% – What’s Next?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) traded down 3.6% during trading on Thursday . The stock traded as low as $9.93 and last traded at $9.7740. 460,905 shares changed hands during trading, a decline of 91% from the average daily volume of 4,852,365 shares. The stock had previously closed at $10.14.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on XRAY shares. Weiss Ratings restated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Monday, August 3rd. BMO Capital Markets decreased their price objective on DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating for the company in a report on Thursday. Piper Sandler raised their price objective on DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 29th. Barclays boosted their target price on DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a research note on Monday, August 24th. Finally, Barrington Research set a $15.00 price target on DENTSPLY SIRONA in a research note on Monday, August 10th. Three analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, DENTSPLY SIRONA has an average rating of “Hold” and a consensus price target of $13.31.

DENTSPLY SIRONA Stock Down 3.8%

The firm has a market capitalization of $1.94 billion, a price-to-earnings ratio of -3.55, a P/E/G ratio of 1.25 and a beta of 0.84. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48. The company’s 50 day moving average price is $12.01 and its 200 day moving average price is $11.54.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.17. The firm had revenue of $898.00 million for the quarter, compared to the consensus estimate of $889.93 million. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%.During the same period in the prior year, the firm earned $0.52 EPS. The firm’s revenue was down 4.1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, research analysts forecast that DENTSPLY SIRONA Inc. will post 1.4 earnings per share for the current fiscal year.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently modified their holdings of the company. BlackRock Inc. acquired a new stake in DENTSPLY SIRONA in the second quarter valued at approximately $283,405,000. Southpoint Capital Advisors LP acquired a new position in shares of DENTSPLY SIRONA during the first quarter worth about $116,000,000. Edmond DE Rothschild Holding S.A. acquired a new stake in DENTSPLY SIRONA in the second quarter valued at $47,780,000. Paradigm Capital Management Inc. NY acquired a new stake in shares of DENTSPLY SIRONA in the 2nd quarter worth approximately $39,775,000. Finally, Bank of America Corp DE acquired a new stake in shares of DENTSPLY SIRONA in the second quarter valued at approximately $31,001,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental laboratories, and other oral health professionals with solutions spanning preventive, restorative, endodontic, orthodontic, implant, and prosthetic dentistry.

Its portfolio includes dental consumables, equipment and treatment centers, imaging systems, CAD/CAM systems, instruments, dental materials, implants, orthodontic products, and software and digital workflow solutions.